Clinical Trials Directory

Trials / Completed

CompletedNCT04368143

COVID-19 Immune Repertoire Sequencing

Status
Completed
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
Institute of Tropical Medicine, Belgium · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This concerns a single-center prospective interventional cohort study. Laboratory-confirmed COVID-19 patients will be asked to donate blood at at least two different timepoints. This will allow us to investigate T and B cell evolutions during the course of infection and recovery. The expected duration of the study is four months or the total duration of the SARS-CoV-2 circulation in Belgium (whichever is shortest).

Conditions

Timeline

Start date
2020-04-01
Primary completion
2021-12-02
Completion
2021-12-02
First posted
2020-04-29
Last updated
2023-10-02

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04368143. Inclusion in this directory is not an endorsement.

COVID-19 Immune Repertoire Sequencing (NCT04368143) · Clinical Trials Directory